MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phagoo, S. B.
Right arrow Articles by Leeb-Lundberg, L. M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Phagoo, S. B.
Right arrow Articles by Leeb-Lundberg, L. M. F.

Vol. 56, Issue 2, 325-333, August 1999

Autoregulation of Bradykinin Receptors: Agonists in the Presence of Interleukin-1beta Shift the Repertoire of Receptor Subtypes from B2 to B1 in Human Lung Fibroblasts

Stephen B. Phagoo, Stephen Poole, and L. M. Fredrik Leeb-Lundberg

Department of Biochemistry, University of Texas Health Science Center, San Antonio, Texas (S.B.P., L.M.F.L.-L.); and Division of Endocrinology, National Institute for Biological Standards and Control, South Mimms, Hertfordshire, United Kingdom (S.P.)

Elevated formation of bradykinin (BK) and Lys-BK or kallidin (KD) and their carboxypeptidase metabolites desArg9BK and desArg10KD is evident at sites of inflammation. Moreover, B2 receptors (B2R), which mediate the action of BK and KD, participates in the acute stage of the inflammatory and pain response, whereas B1 receptors (B1R), through which desArg9BK and desArg10KD act, partake in the chronic stage. We hypothesized that kinins autoregulate B2R and B1R expression in favor of B1R. Incubation of IMR-90 cells with BK (100 nM) led to a loss (89%) of B2R with a half-life (T1/2) of 7.0 min. Concomitantly, BK increased B1R (2- to 3-fold) with a T1/2 of 120 min. DesArg10KD (100 nM) had no effect on B2R but increased B1R (3- to 4-fold) with the same rate as BK. Interleukin-1beta (IL-1beta ; 500 pg/ml) also increased B1R (4- to 6-fold). Although both desArg10KD and BK increased the level of IL-1beta mRNA, IL-1beta receptor antagonist inhibited the increase in B1R only in response to BK. DesArg10KD and BK synergistically increased B1R (9-fold), which was further increased by inclusion of IL-1beta (36-fold). Therefore, kinin metabolism and kinin-stimulated production of cytokines may play a pivotal role in shifting the repertoire of kinin receptor subtypes in favor of B1R during inflammation.


Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Duchene, F. Lecomte, S. Ahmed, C. Cayla, J. Pesquero, M. Bader, M. Perretti, and A. Ahluwalia
A Novel Inflammatory Pathway Involved in Leukocyte Recruitment: Role for the Kinin B1 Receptor and the Chemokine CXCL5
J. Immunol., October 1, 2007; 179(7): 4849 - 4856.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. M. Bertram, S. Baltic, N. L. Misso, K. D. Bhoola, P. S. Foster, P. J. Thompson, and M. Fogel-Petrovic
Expression of kinin B1 and B2 receptors in immature, monocyte-derived dendritic cells and bradykinin-mediated increase in intracellular Ca2+ and cell migration
J. Leukoc. Biol., June 1, 2007; 81(6): 1445 - 1454.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Moreau, M.-T. Bawolak, G. Morissette, A. Adam, and F. Marceau
Role of Nuclear Factor-{kappa}B and Protein Kinase C Signaling in the Expression of the Kinin B1 Receptor in Human Vascular Smooth Muscle Cells
Mol. Pharmacol., March 1, 2007; 71(3): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Enquist, C. Skroder, J. L. Whistler, and L.M. F. Leeb-Lundberg
Kinins Promote B2 Receptor Endocytosis and Delay Constitutive B1 Receptor Endocytosis
Mol. Pharmacol., February 1, 2007; 71(2): 494 - 507.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. H. Bengtson, S. B. Phagoo, A. Norrby-Teglund, L. Pahlman, M. Morgelin, B. L. Zuraw, L. M. F. Leeb-Lundberg, and H. Herwald
Kinin receptor expression during Staphylococcus aureus infection
Blood, September 15, 2006; 108(6): 2055 - 2063.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Sayah, R. Medeiros, E. S. Fernandes, M. M. Campos, and J. B. Calixto
Mechanisms Underlying Lipopolysaccharide-Induced Kinin B1 Receptor Up-Regulation in the Pig Iris Sphincter in Vitro
Mol. Pharmacol., May 1, 2006; 69(5): 1701 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
L. M. F. Leeb-Lundberg, F. Marceau, W. Muller-Esterl, D. J. Pettibone, and B. L. Zuraw
International Union of Pharmacology. XLV. Classification of the Kinin Receptor Family: from Molecular Mechanisms to Pathophysiological Consequences
Pharmacol. Rev., March 1, 2005; 57(1): 27 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. Boix, C. Roe, L. Rosenborg, and S. Knardahl
Kinin peptides in human trapezius muscle during sustained isometric contraction and their relation to pain
J Appl Physiol, February 1, 2005; 98(2): 534 - 540.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. Morissette, J.-P. Fortin, S. Otis, J. Bouthillier, and F. Marceau
A Novel Nonpeptide Antagonist of the Kinin B1 Receptor: Effects at the Rabbit Receptor
J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1121 - 1130.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. S. Kang, K. Ryberg, M. Morgelin, and L. M. F. Leeb-Lundberg
Spontaneous Formation of a Proteolytic B1 and B2 Bradykinin Receptor Complex with Enhanced Signaling Capacity
J. Biol. Chem., May 21, 2004; 279(21): 22102 - 22107.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Souza, E. S. L. Lomez, V. Pinho, J. B. Pesquero, M. Bader, J. L. Pesquero, and M. M. Teixeira
Role of Bradykinin B2 and B1 Receptors in the Local, Remote, and Systemic Inflammatory Responses That Follow Intestinal Ischemia and Reperfusion Injury
J. Immunol., February 15, 2004; 172(4): 2542 - 2548.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. F. Passos, E. S. Fernandes, M. M. Campos, J. G. V. C. Araujo, J. L. Pesquero, G. E. P. Souza, M. C. W. Avellar, M. M. Teixeira, and J. B. Calixto
Kinin B1 Receptor Up-Regulation after Lipopolysaccharide Administration: Role of Proinflammatory Cytokines and Neutrophil Influx
J. Immunol., February 1, 2004; 172(3): 1839 - 1847.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. Ongali, H. d. S. Buck, F. Cloutier, F. Legault, D. Regoli, C. Lambert, G. Thibault, and R. Couture
Regulation of Cardiovascular Signaling by Kinins and Products of Similar Converting Enzyme Systems: Chronic effects of angiotensin-converting enzyme inhibition on kinin receptor binding sites in the rat spinal cord
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H1949 - H1958.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. S. Kang and L. M. F. Leeb-Lundberg
Negative and Positive Regulatory Epitopes in the C-Terminal Domains of the Human B1 and B2 Bradykinin Receptor Subtypes Determine Receptor Coupling Efficacy to G9/11-Mediated Phospholipase Cbeta Activity
Mol. Pharmacol., August 1, 2002; 62(2): 281 - 288.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Sabourin, G. Morissette, J. Bouthillier, L. Levesque, and F. Marceau
Expression of kinin B1 receptor in fresh or cultured rabbit aortic smooth muscle: role of NF-kappa B
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H227 - H237.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Ignjatovic, F. Tan, V. Brovkovych, R. A. Skidgel, and E. G. Erdos
Novel Mode of Action of Angiotensin I Converting Enzyme Inhibitors. DIRECT ACTIVATION OF BRADYKININ B1 RECEPTOR
J. Biol. Chem., May 3, 2002; 277(19): 16847 - 16852.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. E. Marin-Castano, J. P. Schanstra, E. Neau, F. Praddaude, C. Pecher, J.-L. Ader, J.-P. Girolami, and J.-L. Bascands
Induction of Functional Bradykinin B1-Receptors in Normotensive Rats and Mice Under Chronic Angiotensin-Converting Enzyme Inhibitor Treatment
Circulation, February 5, 2002; 105(5): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. B. Phagoo, K. Reddi, K. D. Anderson, L. M. F. Leeb-Lundberg, and D. Warburton
Bradykinin B1 Receptor Up-Regulation by Interleukin-1beta and B1 Agonist Occurs through Independent and Synergistic Intracellular Signaling Mechanisms in Human Lung Fibroblasts
J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 77 - 85.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
D. R. Bachvarov, S. Houle, M. Bachvarova, J. Bouthillier, A. Adam, and F. Marceau
Bradykinin B2 Receptor Endocytosis, Recycling, and Down-Regulation Assessed Using Green Fluorescent Protein Conjugates
J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 19 - 26.
[Abstract] [Full Text]


Home page
J. Leukoc. Biol.Home page
S. Böckmann and I. Paegelow
Kinins and kinin receptors: importance for the activation of leukocytes
J. Leukoc. Biol., November 1, 2000; 68(5): 587 - 592.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
P. G. McLean, M. Perretti, and A. Ahluwalia
Kinin B1 receptors and the cardiovascular system: regulation of expression and function
Cardiovasc Res, November 1, 2000; 48(2): 194 - 210.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. G. McLean, A. Ahluwalia, and M. Perretti
Association between Kinin B1 Receptor Expression and Leukocyte Trafficking across Mouse Mesenteric Postcapillary Venules
J. Exp. Med., July 31, 2000; 192(3): 367 - 380.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. B. Fathy, D. J. Kyle, and L. M. F. Leeb-Lundberg
High-Affinity Binding of Peptide Agonists to the Human B1 Bradykinin Receptor Depends on Interaction between the Peptide N-Terminal L-Lysine and the Fourth Extracellular Domain of the Receptor
Mol. Pharmacol., January 1, 2000; 57(1): 171 - 179.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
L. M. F. Leeb-Lundberg, D. S. Kang, M. E. Lamb, and D. B. Fathy
The Human B1 Bradykinin Receptor Exhibits High Ligand-independent, Constitutive Activity. ROLES OF RESIDUES IN THE FOURTH INTRACELLULAR AND THIRD TRANSMEMBRANE DOMAINS
J. Biol. Chem., March 16, 2001; 276(12): 8785 - 8792.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics